Atlas Trials

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Clinical trial NCT01624220 · COMPLETED

Trial details

NCT number
NCT01624220
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Spinal Tumor
Start date
2012-08-03
Primary completion
2023-04-14
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.